IsraelNationalNews.com

In today's headlines:‏ תג בכותרות

Israeli Pharma Giant Teva Buys Botox's Allergan

$40.5 billion purchase solidifies Teva as world leader in generic drugs, after $40.1 billion bid for rival Mylan meets resistance.Arutz Sheva Staff, 7/27/2015, 1:15 PM

Subsidiary's Crime Costs Teva $1.2 Billion

Israeli pharma giant to pay for illegal monopoly 'pay for delay' move made by company Cephalon - before Teva acquired it.Arutz Sheva Staff, 5/28/2015, 6:17 PM

Shimon Peres to Advise Teva Pharmaceuticals

Consulting job to the tune of $10,000 per month reportedly on the table; details have not been finalized.Tova Dvorin, 4/26/2015, 11:31 AM

Israeli Pharma Teva Looks to Become Global Giant

$40 billion acquisition of US company would launch Teva to unprecedented size - but will its bid be accepted?Arutz Sheva Staff, 4/21/2015, 8:52 PM

Pharmaceutical Giant Teva's Chairman to Resign

Chairman Phillip Frost's announcement the latest in a string of abrupt changes in major Israeli company.AFP, 6/18/2014, 8:04 PM

Teva Setback: Competitors Can Sell Copaxone

A U.S. Supreme Court Justice gave a green light for competitors of Teva to sell generic versions of multiple sclerosis drug Copaxone.Yosef Berger, 4/20/2014, 3:40 PM

Erez Vigodman Named New Teva CEO

Teva on Thursday named Erez Vigodman, 54, as new CEO of the company, after last October's controversial resignation of Dr. Jeremy Levin.Arutz Sheva Staff, 1/9/2014, 2:35 PM

Pfizer Settles with Teva on Generic Viagra

Teva will pay Pfizer a royalty for a license to produce its generic version, from late 2017.Arutz Sheva staff, 12/18/2013, 7:26 AM

Teva Brings 'Captive Profits' Home, Gets Tax Break

Teva said Monday that it would return tens billions of shekels to Israel from abroad, and pay a tax bill of nearly three billion shekels.David Lev, 11/11/2013, 10:08 PM

CEO of Teva Pharmaceuticals Steps Down

Jeremy Levin resigns from the pharmaceutical giant amid tensions in the companyAri Yashar, 10/30/2013, 1:38 PM

Teva: Layoffs Will be Coordinated with Histadrut

After meeting with Histadrut chairman, pharmaceutical giant promises it will coordinate layoff plans.Elad Benari, 10/16/2013, 2:15 AM

Lapid 'Dissatisfied' with Teva Layoffs

Finance Minister says he has spoken to Teva's CEO and asked him to reduce the number of employees the company lays off.Elad Benari, 10/15/2013, 3:15 AM

Teva Laying Off 5,000 Employees

Pharmaceutical firm will reduce global manpower by 10%; 700-800 layoffs expected in Israel.Gil Ronen, 10/10/2013, 5:18 PM

American Jew to Head Teva

American Jew Dr. Jeremy Levin was named new CEO for Teva Pharmaceuticals Monday, when Shlomo Yanai announced he is stepping down. Tzvi Ben Gedalyahu, 1/2/2012, 1:17 PM

Former CEO of Teva Pharmaceuticals Dies at 79

Eli Hurvitz, who served as CEO of Teva Pharmaceutical Industries until 2002, passes away from a serious illness.Elad Benari, 11/22/2011, 2:15 AM

Israeli Drug: No More Insulin Injections?

Two Israeli-based firms try out a peptide aimed at stopping Type 1 diabetes at its source and eliminate the need for insulin injections. Tzvi Ben Gedalyahu, 9/6/2011, 5:48 PM

New Lymphoma Cure Passes Phase 2

A new treatment for lymphoma, a type of cancer, has passed its Phase II clinical trial. CT-011 is produced by CureTech, a Teva company.Hana Levi Julian, MSW, LCSW-R, 5/26/2011, 2:35 PM

Teva Appeals Whopping US Verdict

Israel’s Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, has dedicated its new, $100 million distribution center.Hillel Fendel, 3/7/2011, 11:17 AM

Teva Drugs Approved by FDA

Teva Pharmaceuticals enjoys the approval of two new generics by the US Food and Drug Administration, stocks rise.Malkah Fleisher, 6/29/2010, 11:14 PM

Teva Acquires German Ratiopharm

Israeli pharmaceutical giant Teva has won the bid to acquire German generic drug maker Ratiopharm for $4.9 billion.Hana Levi Julian, 3/21/2010, 12:13 PM

TEVA’s Rx for Investors

Israeli-based TEVA has been called a juggernaut, copy-cat and an 800-pound ape. It makes generic drugs, lots of them, and money – lots of it.Tzvi Ben Gedalyahu, 3/7/2010, 9:37 PM

Teva Partners on Cancer Drug

Israeli pharmaceutical giant Teva has signed a deal to invest $60 million in a new cancer-fighting drug to fight prostate and lung cancer.Hana Levi Julian, 12/22/2009, 2:12 PM